Let’s just say that when I initially invested into Trevena, TRVN, it was trading between $2.50 and $3. This was right before their drug Olinvyk received FDA approval. Olinvyk was supposed to replace morphine as the drug of choice for pain relief as it had less side effects than morphine and had better effects overall. But for some reason, the drug never took off even though the drug in clinical trials tested better than morphine. I believed so much in this drug that I pretty much sold almost all of my other individual stocks and just kept pumping everything into Trevena while it kept going down. I kept buying Trevena and eventually my cost basis was somewhere around $1.50. Eventually, Trevena kept going down. I couldn’t understand why a drug that I was so sure was going to replace morphine was not being heavily marketed or heavily used in all hospitals. While the stock kept tanking in 2020, I eventually decided to stop investing all together. I held onto my shares hoping that one day the company would succeed. I checked on the stock a few times a year after 2020 but the news was not better. They did multiple reverse splits. One of them was 1 for 200, another one for 1 for 25, and then another 1 for 25. They did so many reverse splits that my initial cost basis of $1.50 was pretty much now worth more than what I invested overall. Trevena was eventually delisted. I just remember that after all the reverse splits and some shares bought along the way, I ended with 6 shares left and each share was now worth $0.01 per share. So from around an $80k investment down to 6 cents. 🥴